Physician profile
James L Perrien
NPI 1902099286
$6,362.55
in general payments reported to CMS, 2019-2025
33 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $318 · 2021: $845 · 2022: $848 · 2023: $994 · 2024: $2,102 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,814 · Travel and Lodging: $835 · Education: $9.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,814.25 |
| Travel and Lodging | $835.15 |
| Education | $9.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,240.35 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $743.08 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $637.13 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $304.79 | 2019-2024 | Xarelto |
| Philips North America LLC | $278.94 | 2022-2024 | (Br5) Peripheral Ivus, (Ck4) Mcot |
| Amgen INC. | $254.14 | 2019-2025 | Repatha |
| Shockwave Medical, INC | $185.52 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $153.74 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $132.08 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $126.65 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.09 | 2019-2025 | Jardiance |
| Baxter Healthcare | $92.45 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $90.57 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.30 | 2019-2024 | Lifevest |
| Abbott Laboratories | $88.73 | 2022-2024 | Cardiomems, Diamondback Coronary |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $85.29 | 2021-2024 | Uptravi, Opsumit |
| Inari Medical, INC. | $83.02 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $82.08 | 2019-2020 | |
| Atricure, INC. | $79.10 | 2022-2025 | Synergy Ablation System |
| Abiomed | $65.08 | 2019-2025 | |
| Boston Scientific Corporation | $63.83 | 2025 | Farapulse, Watchman Access System |
| Kowa Pharmaceuticals America, INC. | $62.50 | 2019-2022 | |
| Biosense Webster, INC. | $58.50 | 2023-2024 | Carto 3 |
| Bayer Healthcare Pharmaceuticals INC. | $57.56 | 2021-2022 | |
| Esperion Therapeutics, INC. | $41.03 | 2021-2023 | Nexletol |
| Medtronic, INC. | $30.57 | 2022 | |
| Gilead Sciences, INC. | $26.31 | 2019 | |
| Chiesi USA, INC. | $20.68 | 2019 | |
| Terumo Medical Corporation | $20.34 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $19.43 | 2024 | Arcalyst |
| Otsuka America Pharmaceutical, INC. | $16.96 | 2019 | |
| Kestra Medical Technology Services, INC. | $16.54 | 2022 | |
| Ge Healthcare | $16.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Perrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.